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ABSTRACT
FUNCTION OF THE ENTEROBACTIN OPERON OF A.
ACTINOMYCETEMCOMITANS IN THE PRESENCE OF CATECHOLAMINES AND
IRON
Taylor Johnson
May 13, 2017
Background: Aggregatibacter actinomycetemcomitans (Aa) possesses a two-component
system, QseBC, which is key in biofilm formation/virulence and is activated in the
presence of iron-catecholamine complexes. Aa does not synthesize enterobactin, a
catechol-based siderophore, yet possesses the machinery for recognition and uptake. We
hypothesize that Aa is able to acquire iron by catecholamine mediation through the
enterobactin receptor/transporter. Methods: By insertional mutation, we attempted to
delete the enterobactin permease from the genome using suicide vector pJT1. A growth
curve of truncated mutant ΔfepA was also conducted to observe growth in the presence
of iron and catecholamines. Statistical significance was determined by ANOVA (p<0.05).
Results: The permease deletion mutant was not achieved, but the growth curve for
ΔfepA showed stunted growth in comparison to Wt by 45.4% in a chemically defined
medium (CDM) supplemented with iron and a 38.4% difference in CDM supplemented
with iron and norepinephrine. Conclusions: Given the results from the ΔfepA strain we
can conclude that strains of Aa with mutated enterobactin genes have a reduction in
growth phenotype due to the difficulty in iron uptake.
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CHAPTER 1
INTRODUCTION
A. Periodontal Disease
There are two main forms of periodontal disease, gingivitis and periodontitis.
Gingivitis is a mild inflammation of the gums, characterized by swollen, bleeding and
sometimes painful gingiva with subgingival pocket depths ranging from 4 to 5 mm. With
proper oral hygiene, gingivitis and its symptoms can be reversed, however, if not treated
properly it can progress into periodontitis [2]. Periodontitis and eventually severe
periodontitis is a chronic disease, characterized by damaged soft tissue and supporting
bone, tooth loss and subgingival pocket depths of 6 mm or more. The main etiological
agent that causes the periodontal destruction is the buildup of microbial dental plaque.
Recent studies show that 46% of people aged 30 years or older in the United
States have some degree of periodontal disease, 8.9% of the adult population suffering
from severe periodontitis [3]. The prevalence correlated with age and gender and
occurred more frequently in minorities in comparison to Non-Hispanic whites, displaying
a variation in occurrence based on socioeconomic position.
There are several forms of adult periodontitis, from aggressive and chronic
periodontitis, necrotizing periodontal diseases to periodontitis associated with genetic
disorders [38]. Many factors come into consideration when classifying chronic versus
aggressive periodontitis such as age of onset, the rate of disease progression, pattern of
destruction and the clinical signs of the disease [39]. For example, aggressive
1

periodontitis is usually seen in younger patients and spreads at a much faster rate than
chronic periodontitis normally present in older patients [39].
Acute and Chronic necrotizing ulcerative gingivitis is usually connected with
established gingivitis and factors that may influence the host immune response such as
smoking or drug use [40]. Clinical signs present necrosis of the gingival tissue as well as
pain and bleeding. Other forms of periodontal disease, for example periodontitis that
presents itself due to genetic disorders such as Down’s syndrome, is common [41].
Morphological, anatomical and immunological aspects all play a role in the progression
of the disease.
In 2014 alone, $113.5 billion dollars was spent nationally on dental care, up from
$112 billion in the previous year [4]. Increasing awareness of oral health and advocating
positive oral hygiene could alleviate some of the expenditure. In addition to the great
expenses for dental care in the United States, there is evidence linking periodontal disease
to the onset of other systemic disorders and life-threatening conditions such as
atherosclerosis, osteoporosis, rheumatoid arthritis, diabetes and pregnancy complications
such as preterm birth [5]. These systemic diseases will only add to the increasing cost of
healthcare around the world and signifies the importance of reducing the spread of
periodontal disease in the human oral cavity.
One of the main causes of the onset of periodontal diseases is the buildup of
microbial plaque. If the biofilm of bacteria is not limited by mechanical means or the
naturally occurring antimicrobial activity of saliva, biofilm growth can spread to the
subgingival pocket. The development of a biofilm begins almost as soon as the tooth
erupts during childhood. A protein film called the salivary pellicle covers the tooth to
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prevent continuous deposition of calcium phosphate from the saliva and permits the
attachment of early colonizing bacteria such as the oral streptococci [11]. Eventually,
other microbes attach to the foundation of the biofilm already created by early colonizers.
Coaggregation begins with successive colonization by bacteria such as Actinomycetes,
Prevotella, Eikenella, and Fusobacterium nucleatum [12]. These communities of
commensal and pathogenic bacteria reside on the teeth and are shielded and protected
from antimicrobial salivary proteins and enzymes by the biofilms they create. In healthy
plaque, pathogenic bacteria are usually found in relatively low numbers until some
environmental stimuli triggers an expansion of their populations and expression of their
virulent factors. The expression of virulence factors is hypothesized to be attributed to an
imbalance of bacteria in the oral microbiome, or dysbiosis. This microbial shift is similar
to an overgrowth of bacteria such as H. pylori in the gut leading to conditions like
gastritis and peptic ulcers. Likewise, a flux of the oral bacteria residing in the oral cavity
from mostly gram-positive aerobes to gram-negative anaerobes increases chances of
disease [34]. Although P. gingivalis has been isolated from healthy oral cavities [34], its
presence is usually found when the oral microbiome has shifted to an anaerobic
environment where it causes the most damage [35]. Indeed, P. gingivalis has even earned
the title of a ‘Keystone’ pathogen for its primary role in conditions surrounding
periodontal diseases. Ultimately, expansion of the biofilm in the subgingival pocket
induces an inflammatory response and immune cells such as neutrophils and
macrophages migrate to the site of infection. Eventually, osteoclasts are stimulated either
by the presence of the invading anaerobic bacteria or primarily by the immune response
itself [6,32]. Thus, the host immune response is largely responsible for the deterioration
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of the periodontal ligament and other tissues [31]. Pro-inflammatory cytokines released
from responding immune cells activate osteoblasts to discharge osteoclastic factors such
as IL-1, IL-6, and TNF [6]. Furthermore, components found in the outer membrane of
gram-negative bacteria called lipopolysaccharide (LPS) and endotoxin proteins of
bacteria are pro-inflammatory [6,7]. For example, the fimbriae of P. gingivalis stimulate
the synthesis of chemotactic and osteolytic cytokines from monocytes and fibroblasts
[8,9,10]. The functional consequences of both host and microbial factors cause resorption
of the alveolar bone, leading to bone and tooth loss. There are many pathogenic bacteria
associated with chronic adult periodontitis that also include Treponema denticola,
Tannerella forsythia and Aggregatibacter actinomycetemcomitans [13,14].

Figure 1. Representation of Oral Biofilm. From J.M.F.A. Fernandes, V.A. Menezes, A.J.R.
Albuquerque, M.A.C. Oliveira, K.M.S. Meira, R.A. Menezes Júnior and F.C. Sampaio (2015).
Improving Antimicrobial Activity of Dental Restorative Materials, Emerging Trends in Oral Health
Sciences and Dentistry, Prof. Mandeep Virdi (Ed.), InTech, DOI: 10.5772/59252.
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B. Aggregatibacter actinomycetemcomitans
In 1996, a number of bacteria including A. actinomycetemcomitans were
designated as etiological agents of periodontitis [15]. Aa is a non-motile, gram-negative
facultative anaerobe of the Pasteurellaceae family that is commonly found in the
microbial community of the human oral cavity and indeed exists as a commensal in many
individuals. There are six serotypes of A. actinomycetemcomitans denoted from serotype
‘a’ to serotype ‘f’, with the distribution of affliction depending on the geographic
location. For example, a study conducted in 1998 showed that patients in the United
States displayed significantly higher levels of antibodies to the ‘b’ serotype of A.
actinomycetemcomitans compared to Turkish patients, who showed significantly higher
levels of anti-bodies to the ‘c’ serotype [16]. Recently, a study conducted in the United
States in 2010 observed all serotypes in the oral cavities of the participants, in varying
distributions [36]. Serotype ‘c’ was the dominant serotype, followed by ‘a’ and ‘b’.
Serotypes ‘d’ and ‘e’ were rare, while the prevalence of ‘f’ is still under investigation
[37]. Additionally, patients may harbor just one serotype, or several [36].
A. actinomycetemcomitans is associated with a form of periodontal disease known
as localized aggressive periodontitis (LAP), a disease that affects adolescents, more so in
minority populations [16,17]. In patients of African descent LAP has been shown to be
linked to a lineage of the b serotype, also known as the JP2 clone, which possesses a
deletion in the leukotoxin promoter leading to increased leukotoxin production and
variations in the mechanism for iron acquisition. Interestingly, this suggests that multiple
forms of the disease may exists, one caused by the presence of the JP2 clone and others
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by non-JP2 A. actinomycetemcomitans functioning as an opportunistic pathogen as seen
in European Caucasian populations [16, 18]. What specifically triggers A.
actinomycetemcomitans to exhibit pathogenic characteristics is unclear, but evidence is
beginning to show that the presence of other oral bacteria enhances the virulence of A.
actinomycetemcomitans [15]. In fact, studies have shown heightened growth and
resistance to the host immune response in A. actinomycetemcomitans by the presence of
streptococcus strains, such as S. gordonii [28]. Its ability to resist the host immune
response can partly be attributed to the hydrogen peroxide (H2O2) that is produced by the
streptococci. The presence of H2O2 that is produced as a waste product from the
streptococci induces expression of genes katA and apiA. The gene katA aids in detoxing
the H2O2 into oxygen and water, while apiA boosts auto-aggregation, host cell invasion
and binds to human serum protein factor H which protects A. actinomycetemcomitans
from the complement pathway system [28].
Additionally, A. actinomycetemcomitans secretes a leukotoxin (LtxA), which is a
member of the repeats-in-toxin (RTX) family that specifically target the β(2)-integrin
leukocyte function antigen-1 (LFA-1) that is expressed by white blood cells [30]. The
targeting of this protein leads to apoptosis, or programmed cell death of the white blood
cells. This is accomplished by the internalization of LtxA after binding to LFA-1, where
LtxA is brought to the lysosome. The lysosomal membrane is then disrupted by the
leukotoxin and the lysosomal contents are released into the cytoplasm, killing the cell
[30].
Other virulence factors that allow A. actinomycetemcomitans to reside in the oral
cavity are the fimbriae of the bacteria. Colony variants that arise within a microbial

6

population present different forms of fimbriae, transparent rough, transparent smooth and
opaque [15]. Transparent rough and smooth fimbriae are able to bind to surfaces such as
agar and glass, while the opaque cannot. Antibodies to synthetic A.
actinomycetemcomitans fimbriae blocked binding to saliva-coated surfaces including
buccal epithelial cells displaying the important role fimbriae play in colonizing a host
[15]. Isolating the fimbriae exposed a protein named Flp that was part of a larger open
reading frame that when analyzed revealed a protein structure similar to type IV pili [15].
Clinical isolates of A. actinomycetemcomitans display large fibrils branching off the
organism, which are removed after passaging. These large fibrils resemble the bundleforming fimbriae present on enteropathogenic E. coli, the branching fimbriae cause autoaggregation of A. actinomycetemcomitans [15]. Aggregation of the bacteria allows for
resistance to salivary flow and maintains the presence of the bacteria in the oral cavity.
Other virulence factors responsible for host colonization include the presence of adhesin
proteins on the outer-membrane that mediate cell invasion [15]. Many bacteria possess a
receptor for fibronectin, a glycoprotein of the extracellular matrix of host cells that binds
to components such as collagen, and are able to invade cells by receptor-mediated
endocytosis [20].
There are many factors that allow A. actinomycetemcomitans to reside and be
maintained in the oral microbiome, including the two-component system QseBC.
C. Two-Component System (QseBC)
In order for bacteria to be able to survive in the oral cavity, organisms need to
quickly respond to the local environment that can be in constant flux. One factor that
allows Aa to respond and adapt to environmental fluctuation is a signal transduction
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system, comprised of a two-component system designated QseBC (Figure 2). QseBC
consists of histidine kinase QseC, which is comprised of a periplasmic sensor domain,
two trans-membrane domains and a kinase domain located in the cytoplasm. Binding of
the signal by QseC activates the kinase domain and initiates a cascade that results in the
phosphorylation of QseB. QseB responds to the activation of QseC via a receiver domain
and a helix-turn-helix DNA binding motif, which in turn influences gene expression
(Figure 2) [21].
Different bacteria possess QseBC and rely on its role in virulence [35]. Studies
have shown that QseBC in E. coli is activated by the presence of catecholamines [22].
This activation leads to increased expression of genes responsible for biofilm growth, the
expression of flagella and motility as well as other virulence genes [21]. Furthermore,
QseBC expressed by H. influenzae responds to ferrous iron, but not catecholamines [23].
A. actinomycetemcomitans is unique in that QseBC may be activated by the
presence of iron-catecholamine complexes. Strains of A. actinomycetemcomitans lacking
QseC showed altered phenotypes compared to the wild-type strain, such as significantly
lowered levels of biofilm mass [25] and a reduced capacity of inducing bone loss in a
mouse model of periodontitis [35].
Catecholamines such as norepinephrine or epinephrine act as pseudosiderophores
and are able to strip iron away from host iron-containing proteins such as lactoferrin and
transferrin [24]. Indeed, the role of transferrin is to deliver iron to iron-dependent cells
throughout the body via the circulatory system [19]. Transferrin and lactoferrin are also
associated with the innate immune system. As a result of the high affinity for iron,
exhibited by transferrin and lactoferrin, there are relatively low levels of free iron in the
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body, making it inaccessible to bacteria. However, the presence of stress hormones in
response to inflammation such as gingivitis may result in an environment that is rich in
catecholamines. Since lactoferrin is also released by neutrophils, bacteria may then be
able to utilize these stress hormones to acquire an essential nutrient via by catecholaminemediated iron acquisition.
In order to acquire iron, bacteria secrete siderophores into the extracellular space
of their environment. Siderophores have a high affinity towards iron and bacteria are able
to transport the iron into the cell once the siderophore receptors on the outer membrane
recognize the complex. E. coli and other enteric bacteria utilize the siderophore
enterobactin. Studies have shown that enterobactin is vital as the final acceptor of iron
from iron-catecholamines complexes [26]. Mutant strains of E. coli defective in either
enterobactin synthesis or siderophore uptake were placed in the presence of transferrin
and norepinephrine. Results showed significant decreases in iron uptake, indicating that
enterobactin is required for obtaining iron from catecholamines [24,26]. When the
mutations were complemented back into the bacteria, the ability to accept iron stolen
from transferrin in the presence of norepinephrine was restored. Additionally, research
showed the shuffle of iron from loaded transferrin to unloaded transferrin in the presence
of norepinephrine, supporting that the catecholamines are able to stimulate shuffling of
iron bound to molecules such as transferrin [26].

9

Figure 2. TCS QseBC. From Weigel, W.A. and Demuth, D.R. QseBC, a two-component bacterial
adrenergic receptor and global regular of virulence in Enterobacteriaceae and Pasteurellaceae. Mol
Oral Microbiol. 2016. 31(5): p. 379-397.

D. Enterobactin Operon
Interestingly, A. actinomycetemcomitans does not synthesize enterobactin, a
catechol-based siderophore, yet possesses an enterobactin operon that codes for the
recognition and uptake of it. This may suggest that A. actinomycetemcomitans has
evolved to be an opportunistic pathogen, taking advantage of the host environment. With
the evidence that QseBC is activated in the presence of iron-catecholamine complexes
and the possession of enterobactin machinery for the uptake of enterobactin, this raises
the question of the relationship between the enterobactin operon and stress hormone
mediated iron acquisition.
The enterobactin operon consists of six genes, encoding proteins that make up the
machinery for recognition and uptake of enterobactin (figure 3). The first set of genes
10

encoded on the operon is an iron ABC-family transporter. Specifically, the first operon
gene, annotated as 1357 of serotype c D11S-1 codes for a solute-binding protein of the
ABC transporter, D11S_1356 codes for the permease protein and D11S_1355 codes for
an ATP-binding protein. The enterobactin ABC transporter for bacteria that synthesize
the siderophore is important for transport of iron into the cell. ABC transportation is a
form of active transport, which requires adenosine triphosphate (ATP) to translocate
solutes across the cell membrane. The solute is then imported through a transmembrane
protein permease from the periplasm to the cytoplasm.
Genes D11S_1354 codes for a TonB-dependent outer membrane siderophore
receptor protein designated as fepA. This receptor is present on the outer membrane of
gram-negative bacteria and is a member of the beta-barrel protein family. FepA is an
essential outer membrane porin protein that is involved in the import of iron from the
extracellular space to the periplasm of gram-negative bacteria, mediated by siderophores.
Thus the flow of iron acquisition is the recognition of ironbound enterobactin by outer
membrane receptor FepA, which brings the molecule into the periplasm where it is
recognized by the ABC transporter and transported into the cytoplasm.

Figure 3 [42]. Enterobactin Operon. From Weigel, Whitney, "Functional characterization of
Aggregatibacter actinomycetemcomitans QSEBC : a bacterial adrengeric receptor and global
regulator of virulence." (2015). Electronic Theses and Dissertations. Paper 2296.

Solute- binding

Permease

ATP-binding
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FepA

E. Significance
Microbial endocrinology is an emerging field in which the relationship between
bacterial organisms and host hormones present during infection are observed [27]. When
the body is under some kind of stress, like the inflammation that occurs during
periodontal disease, stress hormones are released. Stress stimulates the release of
neurotransmitter catecholamines like epinephrine or norepinephrine by the sympathetic
nervous system, putting the body in the “flight or fight” state.
The combination of the release of stress hormones and the immune response puts
bacteria in a perfect position to take advantage of the environment. As cells associated
with the immune system, e.g., neutrophils, respond to the area of infection, additional
stress hormone and iron-chelating molecules are released. Thus the presence of both
stress hormone and iron-complexes allow for catecholamine mediated iron acquisition for
any inhabiting bacteria, benefiting from both the stress and immune response.
As previously stated, although A. actinomycetemcomitans does not synthesize the
siderophore enterobactin, it does encode the transportation system for recognition and
uptake of the molecule. There is also evidence that the two-component system QseBC is
activated in the presence of iron-catecholamine complexes, leading to an induction of
genes responsible for anaerobic metabolism and respiration and a down regulation in
genes encoding iron acquisition [21]. This is possibly a result of the bacteria sensing an
iron rich environment and spends less energy in trying to bring in large amounts of iron.
The importance of QseBC in virulence and the ability of pseudosiderophores may
suggest that A. actinomycetemcomitans has evolved to utilize stress hormone mediated
iron acquisition without having to spend the energy in producing enterobactin. Therefore,
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the hypothesis of this thesis is that A. actinomycetemcomitans acquires iron by stress
hormone mediation through the enterobactin receptor/transporter.
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CHAPTER II
METHODS
PART I: INSERTIONAL MUTAGENESIS
To study the role between the enterobactin operon, the acquisition of iron and its
possible influence on the expression of QseBC, mutant strains of Aggregatibacter
actinomycetemcomitans (Aa) lacking genes responsible for iron acquisition were
analyzed. Specifically, studies will observe strains of Aa with inhibited outer membrane
receptor FepA or deletion of the intermembrane permease.
A. Preparation
Stocks of Aggregatibacter actinomycetemcomitans wild-type strain 652 serotype ‘c’
were grown overnight in 50 mL of Brain Heart Infusion medium (BHI: 37g BHI powder
per liter, pH 7.4 ± 0.2), pelleted, resuspended in 1 mL BHI and 1 mL glycerol and stored
in a -80°C freezer. Wild-type strain 652 was grown in 10 mL brain heart infusion
overnight and genomic DNA was obtained from the culture via Promega ‘DNA
Purification System Miniprep’ following the manufacturer’s protocol. The insertional
mutation was carried out using the suicide vector pJT1 (Figure 4). Strains of XL1-Blue
Escherichia coli, electrocompetent cells containing the plasmid pJT1, were grown
overnight in 50 mL Luria Bertani medium (25g LB powder per liter, pH 7.0 ±0.2) and
stored in a -80°C freezer. To acquire the plasmid, the pJT1 containing E. coli were
inoculated into 10 mL LB and placed in an incubated shaker overnight at 37°C. The
plasmid was then isolated via plasmid prep kit ‘QIAprep Spin
14

Miniprep Kit’ by Qiagen following the provided protocol. Both A.
actinomycetemcomitans genomic DNA and pJT1 are rehydrated with nuclease free water
and stored in a 4°C refrigerator.
B. Polymerase Chain Reaction (PCR)
Standard polymerase chain reactions were carried out via the use of Radiant ‘HiFi
ultra DNA Polymerase’ following the protocol provided using the BioRad Mycycler
Thermal Cycler. This was used to amplify the flanking genes (D11S_1357 and 1355) of
the enterobactin permease (D11S_1356) of the Genomic DNA of A.
actinomycetemcomitans D11S strain. The primers used in the reaction are listed in the
table below.
Table 1. PCR Primer Sets
Primer Name
TJ24 (F*)

Sequence 5’- 3’
GGAAATTCCCATGGCGGCCGCAAAAAAT
GG
TJ25 (R*)
GCCGGCAAACTCGAGATCCCCCG
TJ26 (F*)
GGGGCAGACGATGCTCGAGAATTTAGTG
G
TJ27 (R*)
GTACGTCCTTGGGCTGCAGGTTGAGTAA
AAAC
*F denotes Forward Primer; R denotes Reverse Primer; underlines portions
represent restriction enzyme sequences

Figure 4. Representation of Primer Amplification Regions.
TJ24

TJ26

TJ25

TJ27
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The PCR reaction mix was as follows:
- 10µL Radiant 5X HiFI Ultra Reaction Buffer
- 2µL Forward Primer (10µM)
- 2µL Reverse Primer (10µM)
- 1µL gDNA
- 0.5uL Radiant HiFi Ultra Polymerase (2u/µL)
- 34.5µL PCR-grade water
The following table displays the PCR program settings:
Table 2. PCR Settings.
Cycles
Temperature
1
95°C
25-35
95°C
55°C to 65°C
72°C

Time
1 minute
15 seconds
15 seconds
30 seconds per Kb

Notes
Initial Denaturation
Denaturation
Annealing
Extension

The PCR product was observed by gel electrophoresis, purified using a PCR clean
up kit and stored in a 4°C refrigerator.
Gel Electrophoresis Preparation:
1% agarose gel was prepared by dissolving 1 gram of molecular biology grade
agarose powder in 100 mL of 1X Tris-acetate-EDTA (TAE) buffer. The mixture was
heated in a conventional microwave until all agarose powder has melted into solution. It
was allowed to cool before adding 5 µL of Midori Green Advance DNA stain. Once the
gel had set, the gel was carefully transferred to an electrophoresis chamber (1X TAE
buffer). 10 µL of 1KB ladder (Figure 4) was then added to the first well to help quantify
the size of the PCR product. Samples (10 µL) were mixed with some dye (5 µL) and
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subsequently added to the neighboring wells. A current was applied to the chamber
(≅100V) for 50 minutes and visualized under UV light.
C. Digestion
Amounts of up to 1 µg of PCR product were used for the digestion process. Digestions
occur to make specific cuts along the genomic DNA and plasmid pJT1 DNA for ligation
later in the experiment using specific restriction enzymes. The upstream and downstream
PCR product portions and pJT1 are digested with the appropriate restriction enzymes
based upon the flanking genes (D11S_1357 and D11S_1355) and the MCS portion of
pJT1 (Figure 14) and incubated at 37°C overnight. To prevent self-ligation of the plasmid
during the ligation phase, terminal 5’-phosphate groups are removed by a phosphatase
and incubated at the same temperature for an additional hour.
Table 3. Digestion Set-up.
Digestion 1

Digestion 2

Digestion 3

X µL TJ24+25

X µL TJ26+27

X µL pJT1

1 µL NotI

1 µL XhoI

1 µL NotI

1 µL XhoI

1 µL PstI

1 µL PstI

10% total vol. Buffer 3.1

10% total vol. Buffer 3.1

10% total vol. Buffer 3.1

Remaining µL H2O

Remaining µL H2O

Remaining µL H2O

= Total µL

= Total µL

= Total µL

X is determined by ng/µL
Nucleic acid quantitation was determined by a nanodrop spectrophotometer
machine and used to calculate the amount of the digestion product used for the ligation
portion of the experiment. Following the clean up of the digestion product, the three
samples were combined for ligation.
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Figure 5. Plasmid pJT1. From Juárez-Rodríguez MD, Torres-Escobar A, Demuth
DR. Construction of new cloning, lacZ reporter and scarless-markerless suicide
vectors for genetic studies in Aggregatibacter actinomycetemcomitans. Plasmid, 2013.
69(3): p. 211–22.

pJT4 (B), the transcriptional/translation reporter plasmid

D. Ligation

pressed similar levels of activity (see Table 4),
equation below was used to calculate the amount from each of the digestion
hat pJT5 functions as aThe
transcriptional/translater plasmid for studies of gene expression in
products needed
the ligation.
used to determine the amount of each digestion
etemcomitans. Plasmid
pJT3, for
pJT4,
pJT5It is
and
tably maintained for 50 or more generations
needed
(X ng) forconditions
successful ligation:
mycetemcomitansproduct
under
selective
omycetemcomitans transformant cells [OD600nm
= (10ngml
vector)(bp
insert)/(3.8bp pJT1)
"1
! 109 colony forming, CFU,Xunits
)] prosame amount of each recombinant plasmid
Once the amount needed was calculated, the three samples were then added
"1
) as pYGK (not shown). pJT4 and pJT5 are
2 kbp smaller than the pYGK plasmids from
together in a microcentrifuge tube, incubated at 55°C for 5 minutes and T4 ligase, T4
were derived.

ligase buffer and water were then added to the mixture. The ligation was placed in a 4°C

carless-markerless suicide plasmid

refrigerator for at least 48 hours.

de plasmid pJT1 (Fig. 3D) carries the pUC origin
n and does not replicate in A. actinomycetemaddition, pJT1 is a sucrose-sensitive suicide
aining the Bacillus subtilis sacB gene encoding
harase. This gene is lethal in most Gram-negaa in the presence of sucrose (Gay et al., 1983)
provides strong selection for isolation of
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E. Electroporation
The ligation mix was then electroporated into 50 µL electrocompetent E. coli
using the BioRad ‘Micropulser’ on the setting ‘EC1’ in a 0.1 cm cuvette (1.8kV). The
cells were quickly nourished with 500 µL of Super Optimal broth with added Catabolite
repression (SOC, see Table 4 below) and placed in a shaking incubator at 37°C for one
hour. After incubation, the culture was then distributed to LB/spectinomycin agar plates
in 3 µL droplets and incubated at 37°C for 24 hours.
Table 4. Stock Solution of 1X SOC Media.
Amount
Compound
100 µL
NaCl
125 µL
KCl
500 µL
MgCl2
500 µL
MgSO4
1 mL
Glucose

Concentration
5M
1M
1M
1M
1M

F. Plasmid Extraction
Spectinomycin resistant E. coli colonies were collected individually and grown
over night in 10 mL of LB supplemented with 10 µL of spectinomycin. The complete
plasmid construct was isolated by using the Qiagen ‘Spin Miniprep Kit’, nucleic acid
quantitation was determined by nanodrop and stored in a 4°C refrigerator. To verify that
the correct cuts were made during the digestion phase of the experiment, an additional
digestion was carried out to identify both the plasmid pJT1 and the two flanking gene
fragments of genes D11S_1357 and D11S_1355. To do so, 1 µg of each plasmid was
digested with the appropriate restriction enzymes (Table 5).
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Table 5. Construct Digestion
Digestion Digestion Digestion Digestion Digestion Digestion Digestion
1
2
3
4
5
6
7
1 µg
1 µg
1 µg
1 µg
1 µg
1 µg
1 µg
Sample 1
Sample 2
Sample 3
Sample 4
Sample 5
Sample 6
Sample 7
1 µL NotI 1 µL NotI 1 µL NotI 1 µL NotI 1 µL NotI 1 µL NotI 1 µL NotI
1 µL PstI 1 µL PstI
1 µL PstI
1 µL PstI
1 µL PstI
1 µL PstI
1 µL PstI
1/10 total 1/10 total 1/10 total 1/10 total 1/10 total 1/10 total
1/10 total
µL Buffer µL Buffer µL Buffer µL Buffer µL Buffer µL Buffer µL Buffer
3.1
3.1
3.1
3.1
3.1
3.1
3.1
Remaining Remaining Remaining Remaining Remaining Remaining Remaining
µL Water µL Water µL Water µL Water µL Water µL Water
µL Water
G. Sequencing
Using the same conditions referenced in part B; gel electrophoresis is conducted
with the samples and observed under UV light. Samples showing DNA bands at both 3.8
KB (indicating pJT1) and 1400 base pairs (indicating fragments TJ24/25 and TJ26/27)
were selected and prepared for sequencing. For sequencing, 400 ng of the plasmid were
prepared as well as primer for the DNA sequencing process, MDJR 263.
Table 6. Set-up for Plasmid Sequencing
Sample
400 ng Construct
1 µL Primer MDJR
263
Remaining µL
Water
= 12 µL Total
Data from The Center for Genetics and Molecular Medicine Sequencing Service
of the University of Louisville will suggest whether or not there was successful ligation
of plasmid pJT1 and genomic DNA of A. actinomycetemcomitans by identifying specific
genomic sequences unique to the flanking genes D11S_1357 and D11S_1355 and the
plasmid pJT1. Stocks of E. coli containing the full construct were grown overnight,
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prepared for storage and stocked in an -80°C freezer.
H. Electroporation of Plasmid Construct into A. actinomycetemcomitans
Plasmid pJT1 was isolated from the strains of E. coli containing the complete
construct using the Qiagen ‘Spin Miniprep Kit’ following the protocol provided by the
manufacturer. Amounts of up to 20 µg of the plasmid were electroporated into competent
A. actinomycetemcomitans using the BioRad ‘Micropulser’ on the setting ‘EC1’ in a 0.1
cm cuvette (1.8kV). The cells were then quickly nourished with 500 µL of SOC media
(Table 4), incubated at 37°C for one hour under anaerobic conditions and distributed onto
a BHI/Spectinomycin agar plate in 3 µL droplets. 48 hours later, spectinomycin resistant
colonies were collected, grown overnight in 50 mL of BHI supplemented with
spectinomycin, prepared for storage and stocked in a -80°C freezer.
I. Passaging
Successfully electroporated A. actinomycetemcomitans will present
spectinomycin resistant growth. To verify successful integration, the genomic DNA of a
colony was analyzed with diagnostic primers (Table 7) via PCR (Figure 8).
Spectinomycin resistant Aa was inoculated into 1 mL of BHI supplemented with 1 µL of
spectinomycin and incubated overnight at 37°C. The following day, 5 µL was taken from
the overnight culture, placed into a fresh microcentrifuge tube containing the
BHI/Spectinomycin and incubated overnight. The next 3 days, 5 µL was taken from each
previous passage and passaged into just 1 mL of BHI and incubated overnight. After the
third passage in BHI, 5 µL was passaged into 1 mL of Tryptone Yeast Extract (TYE)
broth and the process was repeated for the next 3 days. On the ninth day, 5 µL was taken
from the previous passage and inoculated into 1 mL TYE containing 1 µL, or 1%,
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Isopropyl β-D-1-thiogalactopyranoside (IPTG). IPTG induces the transcription of the
sacB gene of pJT1, which encodes levanesucrase. Levanesucrase is lethal to gramnegative bacteria. Any growth after the addition of IPTG provides a strong selection for
A. actinomycetemcomitans cells that have undergone double recombination to eliminate
sacB. To select the bacteria that have undergone this double recombination, cultures were
diluted to 1x10-5 the original amount and streaked onto TYE/1% IPTG/40% sucrose agar
plates and incubated at 37°C under anaerobic conditions for 48 hours.
J. Double Recombinant Selection
Sucrose resistant colonies were replica plated onto to TYE/1% IPTG/40%
Sucrose agar plates and BHI/Spectinomycin agar plates. The purpose of doing so was to
confirm and select the desired phenotype observed on the primary plate, in this case
sucrose resistant/spectinomycin sensitive Aa colonies. The plates were incubated again
for 48 hours at 37°C under anaerobic conditions. Sucrose-resistant/spectinomycin
sensitive colonies were collected, grown overnight in 10 mL BHI, prepared for storage
and placed in a -80°C freezer.
Colonies were grown overnight in 1 mL of BHI, centrifuged and resuspended in 1
mL of purified water three times to obtain usable genomic DNA of any potential mutant.
The PCR conditions were similar to the protocol described in part B, however the initial
denaturation phase is increased to two minutes to verify cell lysis of the colony samples
obtained.
Colony PCR:
-

2 µL Colony gDNA

-

2 µL M7 (F)
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-

2 µL M6 (R)

-

10 µL Radiant 5X HiFI Ultra Reaction Buffer

-

0.5 µL Radiant HiFi Ultra Polymerase (2u/µL)

-

33.5 µL Water

The PCR products were observed under UV light after gel electrophoresis (same
conditions as part B). Diagnostic primers were created to observe the possibility of the
deletion of gene D11S_1356. Forward primer M7 began shortly upstream of the original
upstream fragment of D11S_1357 and reverse primer M6 began shortly downstream of
the original downstream fragment of gene D11S_1355. The wild type strain should show
a size of around 2800 base pairs, any colony PCR that resulted in a reduced size indicates
a mutation and will be collected, grown up overnight in BHI and stocked in a -80° freezer.
Table 7. Diagnostic Primers

Primer Name
M7 (F)
M6 (R)

Sequence 5’-3’
GACGATTTTGCACCCGAAGTGCAA
GGTGCAAATAAATCTTCTAAAAACACAAATGCC

PART II
WT/ΔFEPA GROWTH STUDIES
Outer membrane receptor, FepA, recognizes iron in the extracellular spaces and
imports the resource into the periplasmic space of Aggregatibacter
actinomycetemcomitans. Observing the effects on the growth of ΔfepA strains of Aa in an
environment supplemented with iron and stress hormone may support the hypothesis of
the role of the enterobactin operon in iron acquisition.
A. Preparation
Stocks of ΔfepA strains were inoculated into 50 mL of BHI and incubated
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overnight at 37°C under anaerobic conditions. They were then centrifuged, resuspended
in 1 mL BHI/1 mL glycerol and stored in a -80°C freezer.
B. Growth Study
Twelve 50 mL conical tubes will be prepared for each strain with triplicates of
each of the four conditions. The four conditions are: CDM, CDM supplemented with 100
µM ferrous chloride, CDM supplemented with 50 µM norepinephrine, and CDM
supplemented with both 100 µM ferrous chloride and 50 µM norepinephrine. Each
conical tube will receive 200 µL of the appropriate strain of A. actinomycetemcomitans,
20 µL of 100 µM ferrous chloride into each tube that requires iron and 20 µL of 50 µM
norepinephrine into each tube that calls for catecholamine.
The growth of each strain of A. actinomycetemcomitans in each of its conditions
was checked at 4, 12, 24, 36, and 48 hours by a spectrophotometer at wavelength of 600
nm. To do so, 4 mLs from each conical tube was taken and placed into a 10 mL conical
tube, centrifuged and resuspended in 1 mL of BHI. The bacterial concentrations were
then measured at a setting of OD600. Each of the triplicates from the two strains in their
four conditions were compared to a blank of 1 mL BHI. The data for each triplicate was
averaged and compared to the other strain.
C. ΔFepA Growth With Transferrin
Wild type and ΔfepA strains of A. actinomycetemcomitans were grown over night
in 10 mL of BHI, centrifuged and resuspended in 10 mL of CDM. Both strains of A.
actinomycetemcomitans were inoculated into a solution of CDM and 100 µM/mL holoTransferrin (1,200 – 1,700 ppm iron content) and CDM supplemented with both 100 µM
holo-Transferrin and 50 µM norepinephrine. A 48-well plate was used for this study.
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Each well will receive 1 mL of each environment for both wild type and ΔfepA strains of
A. actinomycetemcomitans, in triplicate. Readings were taken by a plate reader and
incubated at 37°C under anaerobic conditions and observed at 4, 12, 24, 36, and 48 hours.
E. Apo-Transferrin Control
Wild type and ΔfepA strains of A. actinomycetemcomitans were grown over night
in 10 mL of BHI, centrifuged and resuspended in 10 mL of CDM. Both strains of A.
actinomycetemcomitans were inoculated into a solution of CDM and 100 µM apoTransferrin (<0.005% iron content) and CDM supplemented with both 100 µM apotransferrin and 50 µM norepinephrine. A 48-well plate was used to harbor the bacteria,
each well receiving 1 mL of each environment for both wild type and ΔfepA strains, in
triplicate. The 48-well plate was incubated at 37°C under anaerobic conditions and
measurements of growth were obtained by plate reader at 4, 12, 24 and 36 hours.
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CHAPTER III
RESULTS
PART I: INSERTIONAL MUTATION
The first step in constructing the pJT1 construct was amplifying the flanking
genes of the gene of interest, D11S_1356, by PCR. Following the PCR protocol using Aa
gDNA template and designed primers, the concentration of the PCR product after
purification was: TJ24 + TJ25 = 207.3 ng/µL (Figure 5); TJ26 + TJ27 = 106.3 ng/µL
(Figure 6).
Figure 6. Upstream PCR Product (≈550 bp)

Figure 7. Representation of Upstream PCR Amplification.
TJ24

TJ25
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Figure 8. Downstream PCR Product (≈850 bp)

Figure 9. Representation of Downstream PCR Amplification
TJ26

TJ27

Following the PCR process, pJT1 and the PCR products were digested with
specific restriction enzymes, which make cuts in targeted sequences of the DNA.
Amounts of up to 1 µg of PCR product were digested with the restriction enzymes NotI
and XhoI for the upstream region amplified by primers TJ24,25 and XhoI and PstI for the
downstream region amplified by primers TJ26,27. A 1µg concentration of pJT1 was also
used and digested with restriction enzymes NotI and PstI. This proposes two possible
insertion points of plasmid pJT1 once the products are ligated together, pJT1 inserted into
either upstream gene D11S_1357 or downstream gene D11S_1355.
Results from the digestion process were computed into the equation used for
setting up the ligation process: X = (10ng vector)(bp insert)/(3.8bp pJT1). The
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concentration of the digestion product of pJT1 was 37.4 ng/µL. Taking 1µL of the
digestion into 3.74 µL of water diluted it to 10ng/µL. The fragment of TJ24,25 was a size
547 base pairs, which computed a 1.44 ng requirement. To increase the chances of a
successful ligation, a high flanking region to plasmid ratio was used. Any concentration
up to a 100:1 ratio that did not result in successful ligation would require repeating the
PCR and digestion processes, even redesigning PCR primers. The concentrations
obtained allowed for up to an 80:1 ratio and thus, 4.88µL (115 ng) of Digestion 1 was
taken for the ligation. Likewise, the fragment of TJ26,27 was 856 base pairs, computing a
2.25 ng requirement. Again, an 80:1 concentration was used, calculating to 6.29 µL
(179.89 ng) of Digestion 2 for ligation.
The components were combined to give a total volume of 15 µL as follows:
-

80:1 TJ24+25 4.88 µL

-

80:1 TJ26+27 6.29 µL

-

1:3 pJT1 1 µL

-

T4 DNA Ligase 0.8 µL

-

T4 DNA Ligase Buffer 1.5 µL

-

Water 0.53 µL

The ligation was electroporated into competent E. coli plated onto LB/spec agar
plates where seven colonies grew, indicating successful integration. Plasmid pJT1 is not
suicidal in E.coli and allowed for quantities of the construct to be accumulated and
stored. The plasmids that were isolated from the spectinomycin resistant colonies were
re-digested with the upper restriction enzyme used, NotI, and the lowermost restriction
enzyme that was used, PstI. This would identify the genomic quantity between the cuts
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that were made in the primary digestion. The product of this digestion was then observed
under UV light.
Figure 10. Construct Observation

2

4

The upper DNA marker displays the appropriate genomic quantity for plasmid
pJT1 at 3,800 nucleotide base pairs. Of the seven samples, samples numbers 2 and 4
(table 10) were identified displaying insert fragments consistent with the anticipated
DNA insert of around 1,400 base pairs. These constructs were prepared and sent for
sequencing. The data received from the sequencing department identified the upstream
and downstream fragments D11S_1357 and D11S_1355, suggesting a successful ligation
with plasmid pJT1.
This construct was then electroporated into electrocompetent A.
actinomycetemcomitans resulting in five spectinomycin resistant colonies, indicating a
single recombination. Genomic DNA of the spectinomycin resistant colonies was
obtained using Promega ‘DNA Purification System Miniprep’ and diagnostic primers
were used to sequence the DNA within the parameters (Table 7). The PCR identified
both the D11S_1357/1355 fragment at approximately 1,400 base pairs, and the
homologous chromosome of the host, D11S_1357/1356/1355 (Figure 8).
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Figure 11. Colony PCR After Integration Displaying Host Chromosome and
Construct.

55

.
These colonies then began the passaging phase to select for the colonies that had

undergone a double recombination by presence of growth in sucrose. The colonies that
grew in the presence of sucrose were diluted and plated on a TYE/IPTG/40% sucrose
plate. After incubation, the colonies that grew were replicate plated onto another
TYE/IPTG/40% sucrose plate and a BHI/spectinomycin plate. Again, after incubation, 48
colonies that expressed spectinomycin sensitivity and sucrose resistance were collected
[insert picture]. The diagnostic primers M6 and M7 were used (Table 7), with the forward
primer M7 shortly upstream of the original upstream fragment and the reverse primer M6
shortly after the original downstream fragment to verify that gene D11S_1356 had been
deleted. However, colony PCR had revealed the same DNA amount as the wild type,
signifying that the colonies had reverted to wild type (Figure 9).
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Figure 12. Colony PCR Post Passaging Process, Displaying Wt DNA Size (≈2800
bp)

.
To determine whether the plasmid had been maintained in these clones, sucrose
resistant colonies were grown in BHI supplemented with spectinomycin. Interestingly,
growth did occur, meaning that spectinomycin resistance was being retained in these
strains of A. actinomycetemcomitans. A plasmid miniprep was conducted, resulting in a
low concentration of 10 ng/µL of plasmid. To verify that the plasmid pJT1 had not
mutated, the same stock used in the ligation process above and a new stock of pJT1 was
electroporated into competent A. actinomycetemcomitans. Indeed, no growth occurred,
which verifies that the plasmid pJT1 had not been altered before its electroporation into
A. actinomycetemcomitans.
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PART II: Wt/ΔfepA Growth Study
Although Δpermease strains of A. actinomycetemcomitans were not obtained, this
study was intended to help answer the question of the relationship between the
enterobactin operon and the presence of iron-catecholamine complexes. With a mutation
in the FepA outer membrane receptor, the results are anticipated be similar to Δpermease
strains due to the inability to import and utilize the complex. Comparing the growth of
the wild type strain of A. actinomycetemcomitans and the ΔfepA strain, results indicate
that the ΔfepA strain is effected by the mutation.
A. Aa Strains Supplemented with Iron Source
Over the course of the 48 hours that the growth curves were observed, the wild
type strain grew on average 45.4% more than the ΔfepA strain. A repeated measure
ANOVA (RM-ANOVA) was conducted to observe the means between the two strains.
Overall, there was significance (p < 0.05) between the two strains with a p-value of
0.0247. To analyze each time point, a two-way ANOVA test was also conducted, which
confirmed significance to take place at the 4-hour (p-value = 0.007) and 24-hour (p-value
= 0.039) mark. These results suggest that the ΔfepA strain is not as effective in acquiring
free iron compared to the wild type strain and indicates the role FepA serves in the cell’s
vitality.
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Figure 13. Growth Curve: CDM + 100µM Fe

B. Aa Strains Supplemented with Iron Source and Stress Hormone
A RM-ANOVA was also conducted on the growth curves that were both
supplemented with iron and norepinephrine. Over the course of 48 hours, there was no
significance in the means (p-value = 0.22). To further analyze, a two-way ANOVA test
was conducted on each of the five time points and confirmed that there was no
significance in the variances of the samples. Although there was no significance between
the two strains over the 48-hour period, the wild type strain grew 38.4% better than the
ΔfepA strain, further demonstrating the important role FepA may play in iron acquisition
[Figure 11].
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Figure 11. CDM + 100 µM Fe + 50 µM Norepinephrine

C. Aa Strains Supplemented with Loaded Iron Source, holo-Transferrin
In vivo, bacteria rarely come across free iron ions. Instead, ironbound molecules
such as lactoferrin and transferrin circulate through the blood stream. To create an
environment similar to this, the iron source from the previous experiment was replaced
with iron-loaded holo-Transferrin. A RM-ANOVA was conducted on the growth curve of
wild-type strain A. actinomycetemcomitans versus the ΔfepA strain, resulting in no
significance difference in the means (p-value = 0.28) between the two strains. To further
analyze the data at each time point, a two-way ANOVA was also conducted to confirm
no significance in the variation between the two strains over the course of the 48-hour
period. This was expected, as seen in other studies [26], with no stress hormone to
encourage the shuffling of iron bound to transferrin, neither strain of A.
actinomycetemcomitans was able to acquire the ion.
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Figure 12. CDM + 100 µM holo-Transferrin
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D. Aa Strains Supplemented with Loaded Iron Source, holo-Transferrin and Stress
Hormone
The stress hormone norepinephrine was then added to the environment. A RMANOVA was conducted on the two strains both supplemented with holo-transferrin and
the catecholamine norepinephrine resulting in no significance (p-value = 0.63) between
the two strains. To further analyze the strains at each time point, a two-way ANOVA was
conducted. It identified significance in variance at the 4-hour mark with a p-value of
0.02, however, all other time points were not significant. Further experimentation with
ΔfepA strains of A. actinomycetemcomitans is encouraged, but the results show that for at
least the first twelve hours, the wild type strain was more able to thrive in that
environment then the ΔfepA strain.
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Figure 13. CDM + 100 µM holo-Transferrin + 50 µM Norepinephrine
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E. Unloaded Iron Source Control
A RM-ANOVA was conducted on the two environments to observe the controlled
experiments. The two environments of CDM supplemented with 100 µM apo-Transferrin
and CDM supplemented with both 100 µM apo- transferrin and 50 µM norepinephrine
displayed p-values of 0.7326 and 0.7613, respectively. There was also no significance in
the means, which was expected with a control group. For the 36 hours that were
recorded, both strains of A. actinomycetemcomitans grew similarly in both environments
(Figure 15).
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Figure 15. Apo- Transferrin Control Graphs
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CHAPTER IV
DISCUSSION
The two-component system called QseBC in A. actinomycetemcomitans is
stimulated in the presence of iron-catecholamine complexes. Without QseBC, biofilm
growth is significantly decreased, displaying the importance the two-component system
plays in the pathogenicity of the bacteria.
Bacteria are able to acquire iron through the synthesis and secretion of
siderophores, molecules that bind to iron and bring it into the cell to be utilized. One of
the common siderophores synthesized is enterobactin, a catechol based siderophore.
Studies have shown that catecholamines, such as norepinephrine, may act as
pseudosiderophores and are able to strip iron from ironbound molecules like transferrin
or lactoferrin. This iron-catecholamine complex can serve as a mediator for iron
acquisition for bacteria with enterobactin acting as the final iron acceptor. However,
those studies show that enterobactin must be present for the bacteria to be able to acquire
the iron [26].
Interestingly, A. actinomycetemcomitans does not synthesize enterobactin, but
possesses and encodes for the machinery that recognizes enterobactin and transports it
into the cell. This lead to the hypothesis that A. actinomycetemcomitans is able to acquire
iron through the enterobactin receptor and transporter it possesses without having to
synthesize enterobactin itself, by stress hormone mediation. To study this, attempts were
made to create mutant strains of A. actinomycetemcomitans, in the hopes of creating a
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deletion mutation in the gene that encoded the permease of the enterobactin ABC family
transporter. However, we encountered complications in constructing the ∆permease
strain.

After

the

electroporation

of

plasmid

pJT1

into

competent

A.

actinomycetemcomitans, spectinomycin resistance was observed. This suggested that
successful insertion of the plasmid occurred into the A. actinomycetemcomitans genome
because the plasmid codes for the resistance to spectinomycin, while wild type A.
actinomycetemcomitans does not and pJT2 should not be maintained in the recombinant
clones.
Double recombination was selected for by the observation of growth in the
presence of sucrose. Sucrose activates the SacB gene in plasmid pJT1, creating polymers
of carbohydrates that are lethal to gram-negative bacteria. Growth did occur, as well as
on the agar plates containing sucrose and IPTG. This phenotype suggests that a
recombination event occurred that deleted plasmid sequences including sacB. However,
after analyzing the sucrose resistant colonies, colony PCR indicated they had reverted
back to wild type, but also displayed a resistance to spectinomycin they did not display
before. The reasoning behind this phenomenon and acquiring true ∆permease strains of
A. actinomycetemcomitans will require additional research.
Strains of a truncated mutant strain of A. actinomycetemcomitans in the FepA
outer membrane receptor were acquired by another student in the lab. This mutation
should lead to an alteration in the recognition of iron-catecholamine complexes, thereby
displaying a phenotype similar to a deletion of the permease. To study this, wild-type and
ΔfepA strains of A. actinomycetemcomitans were inoculated into media containing free
iron as well as iron and norepinephrine. The results showed that the ΔfepA strains had a
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more difficult time growing in both environments. At some time during the study of the
growth curve, the wild type grew significantly better than the ΔfepA strain. Although at
other times there was no significance between the two strains, overall the wild type strain
grew 45.4% more in CDM supplemented with iron and 38.4% more in CDM
supplemented with both iron and norepinephrine over the 48-hour period. There are other
systems for A. actinomycetemcomitans to acquire iron [33], however the enterobactin
operon is the most peculiar, because of its relationship with the siderophore it doesn’t
synthesize as mentioned above. The growth reduction that occurred in the ΔfepA strain
supports the hypothesis of the efficient role of the enterobactin operon in A.
actinomycetemcomitans iron acquisition and the presence of stress hormone.
However, free iron is not usually present in vivo. To create an environment
similar to the oral cavity, the iron source was replaced with transferrin. Comparing the
growth of wild type and mutant strains in the presence of just holo-Transferrin, there was
little difference between them. This is expected, as there is no stress hormone present to
encourage the transferrin to unload its iron content. When the stress hormone
norepinephrine was present, there was a significant difference in growth observed in the
first twelve hours, specifically at the 4-hour mark. This suggests that the wild-type strain
is also able to better utilize the iron-catecholamine complexes than the ΔfepA strain.
These results can lead to other experiments concerning the disruption of the
enterobactin operon. A. actinomycetemcomitans is in a great position when the host
responds to its presence with the immune response. Inflammation causes stress hormones
to be present and cells related to the immune response such as neutrophils release
additional stress hormones and ironbound molecules. With A. actinomycetemcomitan’s
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ability to evade the immune response, the presence of both stress hormone and ironbound
molecules puts the bacteria in a perfect position for catecholamine-mediated iron
acquisition.
Furthermore, the relationship between the enterobactin operon, iron acquisition
and the two-component system QseBC can be further studied once a successful deletion
of the permease gene is achieved. With the evidence that QseBC is activated in the
presence of iron-catecholamine complexes and is needed for virulent properties of
Aggregatibacter actinomycetemcomitans, studying the expression of qseBC may be the
link between the enterobactin operon and iron acquisition. Certain genes are affected
when QseBC is activated, with iron uptake genes down regulated. This may be because
the bacteria has sensed an iron rich environment and diverts energy to expressing other
useful genes, such as metabolism and respiration [21]. A rt-PCR comparing the
expression of qseBC in wild type and Δpermease strains of A. actinomycetemcomitans in
the presence of iron and stress hormone may reveal one of the roles of the enterobactin
operon.
Strains of A. actinomycetemcomitans with a disruption in the enterobactin operon
such as ΔfepA or Δpermease strains could also be studied in a mouse model to determine
its effect on periodontal disease. If it could be shown that the onset or degree of localized
aggressive periodontitis is decreased, the outer membrane receptor FepA or the
intermembrane permease could be the target of therapeutic agents.
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